Exhibit 107
Calculation of Filing Fees Tables
Form S-8
(Form Type)
Acadia Pharmaceuticals Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price per Unit(2) | Maximum Price(2) | Fee Rate | Amount of Registration Fee | |||||||
Equity | Common stock, par value $0.0001 per share | Other(2) | 1,750,000(3) | $18.85 | $32,987,500 | 0.0001102 | $3,635.22 | |||||||
Total Offering Amounts | $32,987,500 | $3,635.22 | ||||||||||||
Total Fee Offsets | — | — | ||||||||||||
Net Fee Due | — | $3,635.22 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also registers any additional shares of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), that may become issuable under the Registrant’s 2023 Inducement Plan (the “Inducement Plan”) as a result of any stock split, stock dividend, recapitalization or similar event. |
(2) | Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee, on the basis of the average of the $19.06 (high) and $18.64 (low) sale price of the Common Stock as reported on The Nasdaq Global Select Market on January 31, 2023, which date is within five business days prior to the filing of this Registration Statement. |
(3) | Represents 1,750,000 shares of the Common Stock reserved for issuance under the Inducement Plan. |